Bowel cancer immunotherapy clinical trial follow-up shows…
0 reactions
Bowel cancer immunotherapy clinical trial follow-up shows zero relapses
Patients with a specific type of bowel cancer who were treated with a short course of immunotherapy before surgery instead of post-op chemotherapy have remained cancer-free after almost three years of follow-up, according to new results from the NEOPRISM-CRC clinical trial led by a team from UCL and UCLH.
#inspiration
Patients with a specific type of bowel cancer who were treated with a short course of immunotherapy before surgery instead of post-op chemotherapy have remained cancer-free after almost three years of follow-up, according to new results from the NEOPRISM-CRC clinical trial led by a team from UCL and UCLH.
#inspiration
| 1,000 mlx | |
| 1 | |
| 0 |